Published in Antimicrob Agents Chemother on December 01, 1997
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther (2015) 1.22
In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657. Antimicrob Agents Chemother (1999) 1.16
Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother (2002) 1.12
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother (2003) 0.99
Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test. J Clin Microbiol (1999) 0.96
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. J Clin Microbiol (1998) 0.96
In vitro antimicrobial susceptibility testing of Helicobacter felis, H. bizzozeronii, and H. salomonis. Antimicrob Agents Chemother (2005) 0.83
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model. Antimicrob Agents Chemother (2002) 0.79
Changes in Antibiotic Susceptibility of Helicobacter pylori in the Course of Eight Years in the Zaanstreek Region in The Netherlands. Gastroenterol Res Pract (2013) 0.78
Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris. J Clin Microbiol (2000) 0.75
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori. Antimicrob Agents Chemother (2000) 0.75
Comparison of a selective and a non-selective medium in the diagnosis of gonorrhoea to ascertain the sensitivity of Neisseria gonorrhoeae to vancomycin. Br J Vener Dis (1972) 2.93
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.85
Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother (1986) 2.26
Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother (1988) 1.85
Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents. Eur J Clin Microbiol Infect Dis (1988) 1.71
Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol (1993) 1.70
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother (1996) 1.42
Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemother (1996) 1.36
Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin. Antimicrob Agents Chemother (1986) 1.31
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori. Antimicrob Agents Chemother (1989) 1.23
Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur J Epidemiol (1988) 1.12
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. Antimicrob Agents Chemother (1989) 1.01
Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol (1995) 1.00
In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics. Acta Pathol Microbiol Immunol Scand B (1987) 0.87
Peptic ulcers and gastric cancer. Br J Biomed Sci (1995) 0.81
Susceptibility of Campylobacter pylori to the newer cephalosporin antibiotics. Chemotherapy (1989) 0.81
Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med (2001) 2.38
Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis. J Clin Microbiol (1977) 2.14
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2001) 2.10
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax (1992) 1.97
Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett (1999) 1.93
Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae. Infect Immun (1983) 1.93
Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2003) 1.91
Crossed immunoelectrophoretic analysis of Legionella pneumophila serogroup 1 antigens. Infect Immun (1983) 1.89
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis (1986) 1.84
Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis (1994) 1.83
The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroenterol (1973) 1.82
Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut (1992) 1.81
Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect (1997) 1.79
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76
The prognosis of ulcerative colitis. Scand J Gastroenterol (1974) 1.74
The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol (1975) 1.67
Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect (1995) 1.63
Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection (1995) 1.61
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect (2007) 1.61
Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. J Lipid Res (1977) 1.60
Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 1.59
Evaluation of eight commercial kits for Helicobacter pylori IgG antibody detection. APMIS (1993) 1.55
Are variable repeats in the spa gene suitable targets for epidemiological studies of methicillin-resistant Staphylococcus aureus strains? Eur J Clin Microbiol Infect Dis (1996) 1.54
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun (1990) 1.51
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.49
Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology (1992) 1.49
Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol (2004) 1.49
Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med (1999) 1.48
In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection (2002) 1.48
Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis (1992) 1.46
Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut (2003) 1.46
Control of a methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a day-care institution. J Hosp Infect (2006) 1.46
Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol (1999) 1.45
Coagulase and protein A polymorphisms do not contribute to persistence of nasal colonisation by Staphylococcus aureus. J Med Microbiol (1997) 1.40
[Prevention of duodenal ulcer recurrence with penicillin]. Ugeskr Laeger (1994) 1.39
Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol (1992) 1.39
The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol (1975) 1.38
An epidemiological study of regional enteritis and acute ileitis in Copenhagen County. Scand J Gastroenterol (1973) 1.38
Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother (1995) 1.37
Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med (1999) 1.36
Survival in peptic ulcer. Gastroenterology (1978) 1.36
Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother (2002) 1.35
Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings. Scand J Gastroenterol (1987) 1.35
Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol (1976) 1.33
An epidemiological study of ulcerative colitis in Copenhagen County. Scand J Gastroenterol (1968) 1.32
[Treatment of upper respiratory tract infections]. Ugeskr Laeger (2000) 1.31
Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception (1989) 1.29
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother (2005) 1.28
Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med (1998) 1.28
Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (1989) 1.28
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut (1997) 1.24
Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods. J Antimicrob Chemother (1999) 1.24
Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med (1986) 1.24
Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scand J Gastroenterol (1980) 1.22
Isolation of a "Helicobacter heilmanii"-like organism from the human stomach. Eur J Clin Microbiol Infect Dis (1996) 1.22
Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori. Clin Diagn Lab Immunol (1995) 1.22
Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J (1977) 1.20
Transport conditions and number of biopsies necessary for culture of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1991) 1.19
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother (1998) 1.19
Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun (1991) 1.18
Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology (1998) 1.16
Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis (1994) 1.16
Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis (1994) 1.16
Quantitative immunoelectrophoretic analysis of Salmonella typhi antigens and of corresponding antibodies in human sera. Acta Pathol Microbiol Scand B (1980) 1.15
Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun (2010) 1.14
Causes of death in duodenal and gastric ulcer. Gastroenterology (1977) 1.14
A cultured strain of "Helicobacter heilmannii," a human gastric pathogen, identified as H. bizzozeronii: evidence for zoonotic potential of Helicobacter. Emerg Infect Dis (2001) 1.14
Isolation of Staphylococcus aureus clumping factor. Infect Immun (1985) 1.14
Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. Am J Obstet Gynecol (1998) 1.14
Clumping of Staphylococcus aureus by human fibronectin. Acta Pathol Microbiol Scand B (1981) 1.14
Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett (1999) 1.10
Hospital-acquired infections in a burns unit caused by an imported strain of Staphylococcus aureus with unusual multi-resistance. J Hyg (Lond) (1982) 1.10
Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology (2000) 1.10
Rapid identification of Capnocytophaga isolated from septicemic patients. Eur J Clin Microbiol (1984) 1.10
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2002) 1.10
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect (1994) 1.08
Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS (1993) 1.08
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol (1990) 1.08